Company News

Virtual Incision Receives FDA Authorization for the MIRA Surgical System as the First Miniaturized Robotic-Assisted Surgery Device

New category challenges industry standards in soft tissue robotic-assisted surgery and has the potential to expand access to minimally invasive care De Novo premarket review pathway establishes initial indication for adults undergoing colectomy procedures and lays the foundation for expansion into other abdominal procedures LINCOLN, Neb. – February [...]

2024-02-26T09:01:21+00:00February 26th, 2024|All News, Company News, Investment, Medtech|

Kenbi acquires major homecare provider, benefitting from liquid M&A opportunities and taking digital disruptor lead

Kenbi acquires major homecare provider, benefitting from liquid M&A opportunities and taking digital disruptor lead Berlin – February 21, 2024 – Kenbi, the German HealthTech start-up with Europe’s only home-healthcare solution ecosystem, today announced the buy out of Brandenburg-based care provider Lioncare. The buyout was supported by a private [...]

2024-02-27T15:18:23+00:00February 25th, 2024|All News, Company News, Investment|

Virtual Incision’s Miniaturized Surgical Robot En Route to the International Space Station for Testing of Long-Range Remote Capabilities

spaceMIRA becomes the first surgical robot in space through partnership with the University of Nebraska and NASA LINCOLN, Neb. and CAPE CANAVERAL, Fla – January 30, 2024 – Virtual Incision Corporation, the developer of the MIRA Surgical System (MIRA), today announced that spaceMIRA is currently in transit to the International [...]

2024-01-30T17:41:56+00:00January 30th, 2024|All News, Company News|

Nalu Medical, Inc. Announces $65 Million Equity Financing to Advance Treatment for Chronic Neuropathic Pain

Proceeds will accelerate commercial growth and expand clinical and health-economic evidence for the innovative Nalu neurostimulation system featuring the revolutionary micro-IPG.™ Series E round led by Novo Holdings and joined by all existing significant investors. CARLSBAD, Calif (BUSINESS WIRE) January 3, 2024 - Nalu Medical Inc. (Nalu), a private company [...]

2024-02-27T15:08:24+00:00January 3rd, 2024|All News, Company News, Medtech|

Nalu Medical, Inc., Announces Positive Results of US Spinal Cord Stimulation Clinical Study in Pain Physician Journal

November 29, 2023 12:00 PM Eastern Standard Time CARLSBAD, Calif.--Nalu Medical, Inc (“Nalu”) is a Carlsbad, California-based company that has successfully miniaturized neurostimulation implants for the management of chronic intractable pain across a variety of targets with both spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) indications. Today [...]

2024-02-27T15:22:23+00:00December 6th, 2023|All News, Company News, Medtech|

Relievant Medsystems — Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.

Recent healthcare plan coverage of Intracept® system expands access to vertebrogenic pain treatment for tens of millions of patients MARLBOROUGH, Mass., Nov. 17, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. [...]

2023-11-20T12:09:39+00:00November 20th, 2023|All News, Company News|

VentureMed Receives Transitional Pass-through Payment (TPT) for FLEX Vessel PrepTM System

Minneapolis, Minnesota, November 8, 2023 - VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced today that the Center for Medicare & Medicaid Services (CMS) has granted The [...]

2023-11-09T16:55:33+00:00November 9th, 2023|All News, Company News|

Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure

REDWOOD CITY, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Gynesonics® Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce that it has secured an incremental $42.5 million in financing (total of $67.2M inclusive of initial April 2023 financing). [...]

2023-11-02T14:28:22+00:00November 2nd, 2023|All News, Company News|

Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids Reaches Patient Milestone

REDWOOD CITY, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce that its Sonata® Procedure has been used to treat over 1,000 women in the United States and approximately [...]

2023-10-18T11:06:33+01:00October 18th, 2023|All News, Company News|

Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.

Acquisition intended to expand neuromodulation portfolio to provide more treatment options for people living with chronic low back pain MARLBOROUGH, Mass., Sept. 19, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that [...]

2024-02-27T15:24:34+00:00September 19th, 2023|All News, Company News|
Go to Top